Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
A 10-year follow-up study by researchers at the Johns Hopkins University School of Medicine reported that an elevated coronary artery calcium (CAC) score, a sign of vascular aging, appears to be an accurate measure of vulnerability ... Read more
University of Louisville cardiologist Andrew DeFilippis, M.D., MSc, was awarded a $100,000 Heart to Heart Grant from the Alpha Phi Foundation to study cardiovascular disease and identify a potential new biomarker ... Read more
The Heart Failure Clinical Research Network (HFN), a group of prestigious clinical centers located across North America, has selected Mast Therapeutics’ product AIR001 for evaluation in the Phase 2 clinical ... Read more
In a new study, researchers demonstrated that the use of primary prevention implantable cardiac defibrillators (ICDs) is associated with improved survival rates and decreased risk of death in women as ... Read more